Non-Small Cell Lung Cancer

People with Non-Small Cell Lung Cancer are asked to participate in a research study being conducted by Monter Cancer Center.

You may be eligible to participate in this study if you:

• Are a male or female at least 18 years of age
• Have histologic or cytologic evidence of NSCLC without histological evidence of a small cell component that is either metastatic (Stage 4) or locally advanced (Stage 3B-C) and unresectable (IASLC 8th edition)
• Have a known KRAS mutation
• Have adequate organ, hepatic, cardiac, and renal function
• Have received appropriate platinum-based therapy
• Have received appropriate treatment with at least one prior systemic regimen
• Have received appropriate therapy for an activating mutation of the epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), or other activating mutation

You may NOT participate in this study if you:

• Have received systemic anti-cancer therapy within 4 weeks of the first dose of study
• Have history of prior malignancy
• Have had major surgery within 4 weeks
• Have had treatment with warfarin
• Have an active skin disorder
• Have a history of rhabdomyolysis
• Have symptomatic brain metastases requiring steroids or other local interventions
• Have known SARS-Cov2 infection ≤28 days prior to first dose of study therapy
• Have known immunodeficiency virus (HIV) infection, hepatitis B or C
• Are pregnant or breastfeeding

Contact Information
Alexa Amoroso, Study Coordinator
450 Lakeville Rd. Lake Success, NY 11042
Phone: (516) 734-8977